This study tested ten such drugs that were developed to target six proteins, five of which (HDAC6, MAPK14/p38α, PAK4, PBK, and PIM1) are known to represent cancer dependencies, and one protein (CASP3/caspase-3) that is the primary executioner in apoptosis. The gene discussed is CASP3; the disease is cancer.